Serum Institute wants to manufacture Russian Covid vaccine Sputnik V in India, seeks DCGI nod

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.